Same Indication

Methotrexate vs Yttrium Y 90 Ibritumomab Tiuxetan

Methotrexate vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between Methotrexate and Yttrium Y 90 Ibritumomab Tiuxetan.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5.

Molecular Weight: Methotrexate — 454.4400 g/mol.

Type: Methotrexate — Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.